1. home
  2. > health
  3. > Gilead says remdesivir shows reduced mortality in Covid-19 study
replay trump newslist
up NEXT IN 5 SECONDS sports newslist
tap to unmute
00:00/00:00
NaN/0

Gilead says remdesivir shows reduced mortality in Covid-19 study

Jul 12, 2020 13:45 IST

American pharma company Gilead Sciences Inc has said that additional data from a late-stage study shows that its antiviral drug remdesivir significantly improved clinical recovery of critically ill Covid-19 patients. The company said 74.4% of remdesivir-treated patients recovered by Day 14 versus 59% of patients on standard care Dr. Susan Olender from Columbia University said in the Gilead statement to Reuters that the analysis 'draws from a real-world setting and serves as an important adjunct to clinical trial data even though it is not as vigorous as a randomized controlled trial.' In contrast, a University of Pittsburgh medical professor said it is a 'joke' to compare clinical trial data with observational data and conclude anything definitive about death risk.

Health